BBP Among Health Care ETFs
End-of-day Nov 13, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.5% | −0.3% | −2.4% | −0.7% | +27.7% | +31.0% | +109.9% | +95.3% | +297.6% |
| Peer average | −0.1% | +0.8% | +3.7% | +4.0% | +21.5% | +25.9% | +71.5% | +27.0% | — |
| S&P 500 · VOO | −0.4% | +2.6% | −2.3% | −2.1% | +11.5% | +11.6% | +79.3% | +72.7% | — |
$64 of every $1,000 in BBP is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 6.41% | $640.78 | 35K | $8.7M |
| 2 | XERSXeris Biopharma | Healthcare | 3.13% | $312.89 | 258K | $4.3M |
| 3 | VSTMVerastem | Healthcare | 2.85% | $285.12 | 428K | $3.9M |
| 4 | OMEROmeros | Healthcare | 2.67% | $267.21 | 201K | $3.6M |
| 5 | IOVAIovance Biotherapeutics | Healthcare | 2.55% | $255.00 | 430K | $3.5M |
| 6 | KNSAKiniksa Pharmaceuticals International | Healthcare | 2.37% | $237.33 | 34K | $3.2M |
| 7 | ADMAADMA Biologics | Healthcare | 2.07% | $206.61 | 214K | $2.8M |
| 8 | BGNEBeOne Medicines | — | 2.04% | $204.20 | 6,628 | $2.8M |
| 9 | REGNRegeneron Pharmaceuticals | Healthcare | 2.02% | $201.50 | 2,863 | $2.7M |
| 10 | ZLABZai Lab | Healthcare | 1.99% | $199.04 | 103K | $2.7M |
| 11 | HALOHalozyme Therapeutics | Healthcare | 1.88% | $188.15 | 25K | $2.6M |
| 12 | ROIVRoivant Sciences | Healthcare | 1.79% | $179.16 | 58K | $2.4M |
| 13 | RIGLRigel Pharmaceuticals | Healthcare | 1.74% | $174.29 | 53K | $2.4M |
| 14 | GILDGilead Sciences | Healthcare | 1.74% | $173.79 | 14K | $2.4M |
| 15 | IRWDIronwood Pharmaceuticals | — | 1.72% | $171.59 | 480K | $2.3M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 6.41% |
| 2 | XERS | Xeris Biopharma | 3.13% |
| 3 | VSTM | Verastem | 2.85% |
| 4 | OMER | Omeros | 2.67% |
| 5 | IOVA | Iovance Biotherapeutics | 2.55% |
| 6 | KNSA | Kiniksa Pharmaceuticals International | 2.37% |
| 7 | ADMA | ADMA Biologics | 2.07% |
| 8 | BGNE | BeOne Medicines | 2.04% |
| 9 | REGN | Regeneron Pharmaceuticals | 2.02% |
| 10 | ZLAB | Zai Lab | 1.99% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 20, 2017 | Dec 27, 2017 | $0.0700 |
| Dec 21, 2015 | Dec 29, 2015 | $0.40 |